ArticleCancer immunology, immunotherapy : CII2016

Histone deacetylase inhibitors enhance CD1d-dependent NKT cell responses to lymphoma.

Irina V Tiper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.